Papaverine HCl Injection recall: Particulate Matter
Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Why was Papaverine HCl Injection recalled?
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 25202, Exp. Date: 11/30/2026.
- Product
- Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
- Recalling firm
- American Regent, Inc.
- Quantity
- 86,100 vials
- Distribution
- Nationwide within the U.S
- Recall date
- August 26, 2026
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)